QT
BBNX icon

Quantbot Technologies’s Beta Bionics BBNX Stock Holding History

Quantbot Technologies’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$264K Sell
16,819
-24,476
-59% -$291K 0.01% 1173
2026
Q1 		$414K Sell
41,295
-48,110
-54% -$712K 0.02% 925
2025
Q4 		$2.72M Buy
89,405
+75,011
+521% +$2M 0.09% 351
2025
Q3 		$286K Buy
+14,394
New +$253K 0.01% 1190

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Quantbot Technologies's BBNX Position: Q2 2026 in Review

Quantbot Technologies reduced its Beta Bionics (BBNX) stake by 59% in Q2 2026, selling an estimated $291K and leaving 16,819 shares worth $264K. The position accounts for 0.01% of the portfolio, ranked #1173.

Quantbot Technologies first reported a position in BBNX in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.72M in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Quantbot Technologies held 16,819 shares of Beta Bionics worth $264K as of Q2 2026.
  • Quantbot Technologies sold 24,476 Beta Bionics shares in Q2 2026, an estimated $291K.
  • Beta Bionics made up 0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1173 holding.
  • Quantbot Technologies first reported a position in Beta Bionics in Q3 2025 and has held it in 4 quarters since.
  • Quantbot Technologies's Beta Bionics position peaked at $2.72M in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.